logo

GMRE

Global Medical Reit·NYSE
--
--(--)
--
--(--)
9.88 / 10
Outperform

Fundamental measurement shows exceptional quality (9.9/10). Constructive metrics: Diluted earnings per share (YoY growth rate %) and Cash-UP, however risks emerge in Net income-Revenue and Asset-MV. Final assessment: exceptionally strong.

Fundamental(9.88)SentimentTechnical

Analysis Checks(2/10)

Revenue-MV
Value-2.02
Score0/3
Weight-112.06%
1M Return-5.91%
Net assets per share (growth rate compared to beginning of year %)
Value345.73
Score0/3
Weight-39.76%
1M Return-1.40%
Net income-Revenue
Value-0.17
Score0/3
Weight-15.40%
1M Return-0.48%
PB-ROE
Value0.72
Score1/3
Weight-60.67%
1M Return-1.98%
Shareholders’ equity attributable to parent company (growth rate compared to beginning of year %)
Value-9.14
Score1/3
Weight-29.57%
1M Return-1.07%
Income tax / Total profit (%)
Value-5.70
Score0/3
Weight-12.87%
1M Return-0.52%
Cash-UP
Value-0.61
Score3/3
Weight423.22%
1M Return8.68%
Diluted earnings per share (YoY growth rate %)
Value-775.00
Score3/3
Weight111.15%
1M Return3.43%
Asset-MV
Value0.51
Score0/3
Weight-103.42%
1M Return-5.45%
Cash-MV
Value-1.31
Score0/3
Weight-60.61%
1M Return-2.40%
Is GMRE fundamentally strong?
  • GMRE scores 9.88/10 on fundamentals and holds a Discounted valuation at present. Backed by its -0.88% ROE, 1.52% net margin, 109.92 P/E ratio, 0.97 P/B ratio, and -420.00% earnings growth, these metrics solidify its Outperform investment rating.